YDES

YD Bio Ltd

YD Bio Ltd (YDES) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-15 D (1.2) A+ (5.0) B (3.5) B+ (3.6) C+ (2.6) B (3.2)
2026-11-08 D- (1.0) A+ (5.0) B (3.5) B (3.2) C+ (2.6) B- (3.1)
2026-11-01 D- (0.9) A+ (5.0) B (3.5) B+ (3.7) C+ (2.7) B (3.2)
2026-10-25 D (1.3) A+ (5.0) B+ (3.5) C+ (2.6) C+ (2.6) B- (3.0)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe